GLP-1s Are Growing In Popularity For Weight Loss But Losing Steam Among People With Diabetes, Study Suggests

Forbes July 22, 2024
Arianna Johnson

Topline

The use of GLP-1 medications like semaglutide for weight loss has increased twofold over the past decade, but declined in use among type 2 diabetics, according to a new study, and the researchers warn the resulting and ongoing drug shortage may limit diabetics’ access to the drugs.

Key Facts

Get Forbes Breaking News Text Alerts: We’re launching text message alerts so you’ll always know the biggest stories shaping the day’s headlines. Text “Alerts” to (201) 335-0739 or sign up here.

What Glp-1s Have Been Approved For Weight Loss?

There are seven approved GLP-1 drugs in the U.S. There’s also a similar class of medications called dual GLP-1 and GIP receptor agonists, and tirzepatide (the generic name for Mounjaro and...

Today's Sponsors

Today's Sponsor